Like any person diagnosed with cancer, the ones who tend to manage it best are those who understand their disease in detail, who know what treatment options are available, the stage of their disease, and their prognosis.
Read MorePSA velocity is the rate at which your PSA level increases from year to year. This rate of change in PSA levels over time, can give crucial information to a doctor about your potential for cancer.
Read MoreA new genetic test has recently become available called Oncotype DX. The test is made by Genomic Health and will now be available at Dr. Samadi's Prostate Cancer Center in New York City. What is Oncotype DX?
Read MoreWhat is Cyberknife? Cyberknife is a form of stereotactic body radiation therapy (SBRT) and robotic-assisted radiosurgery (not actual surgery) that utilizes a computerized robot to automatically deliver high doses of radiation to the prostate gland. Fiducials are implanted into the body so that the Cyberknife machine can adjust to movement during each treatment.
Read MoreProstate cancer is the most common cancer in men. So far, the only tools available to detect and diagnose prostate cancer include: the PSA test and the transrectal ultrasound guided biopsy. Every year, about 20 million PSA tests are performed and about 1.2 million men undergo a biopsy. Traditional techniques such as the TRUS biopsy only sample the lower portion of the prostate – yet almost 30% of cancers are found outside this area. For this reason, only 30-40% of the 1.2 million biopsies performed on men each year are positive for prostate cancer.
Read MoreAfrican-American men have the highest risk of developing prostate cancer, compared all other races. A new study suggests that there are specific genes that may indicate aggressive prostate cancer in African-American men. The researchers believe that their results may partially explain the reason for ethnic disparities in prostate cancer. In the past, ethnic disparities in prostate cancer have been associated with socioeconomic and biologic factors. The study was recently published online in the journal Urologic Oncology.
Read MoreA new study suggests that patients with prostate cancer who have low prostate antigen, or PSA, levels have a higher risk for cancer-specific death compared with patients whose PSA levels are high. A low PSA level was considered less than or equal to 2.5 ng/mL or 2.6 to 4 ng/m, while a high PSA level was considered 10.1 to 20 ng/mL The study was published online in the journal Cancer.
Read MoreProstate cancer is the second most common cancer among men in the United States. African-Americans have the highest risk of developing prostate cancer among any other racial group. Prostate cancer in African-American men also tends to be more aggressive.
Key statistics about African-American men and prostate cancer:
Read MoreSex is beneficial for prostate health. It is also beneficial for many other health reasons. In regards to prostate health, sex may decrease your risk for prostate cancer. A previous study showed that men who ejaculated at least 21 times a month were less likely to develop prostate cancer. This doesn’t mean you need to have a sex partner – whether it be sexual intercourse, nocturnal emission, or masturbation, all are beneficial.
Read More
